Neuren Pharmaceuticals Limited (ASX:NEU)
Australia flag Australia · Delayed Price · Currency is AUD
12.44
+0.64 (5.42%)
May 2, 2025, 4:10 PM AEST

Neuren Pharmaceuticals Revenue

In the year 2024, Neuren Pharmaceuticals had annual revenue of 216.83M AUD, down -6.51%. Neuren Pharmaceuticals had revenue of 192.51M in the half year ending December 31, 2024, with 1,148.65% growth.

Revenue
216.83M
Revenue Growth
-6.51%
P/S Ratio
7.20
Revenue / Employee
27.10M
Employees
8
Market Cap
1.56B

Revenue Chart

Created with Highcharts 11.4.8Neuren Pharmaceuticals Revenue - Annual717.00K717.00K3.20M3.20M15.42M15.42M231.9M231.9M216.8M216.8M20202021202220232024-50M100M150M200M250M

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024216.83M-15.11M-6.51%
Dec 31, 2023231.94M216.53M1,404.46%
Dec 31, 202215.42M12.22M382.23%
Dec 31, 20213.20M2.48M345.89%
Dec 31, 2020717.00K222.00K44.85%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Telix Pharmaceuticals 783.21M
Ramsay Health Care 17.12B
Ansell 3.00B
Mesoblast 9.16M
Revenue Rankings